Valirx Plc (VAL.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,556 | 175 | 1,137 | 594 | 1,847 |
| Inventories | 69 | 69 | N/A | N/A | N/A |
| Other current assets | 272 | 323 | 325 | 205 | 137 |
| TOTAL | $1,897 | $566 | $1,464 | $800 | $1,985 |
| Non-Current Assets | |||||
| PPE Net | 202 | 243 | 6 | 13 | 21 |
| Intangibles | 2,133 | 2,321 | 2,506 | 2,711 | 2,932 |
| Other Non-Current Assets | 30 | 0 | 0 | 0 | 0 |
| TOTAL | $2,365 | $2,564 | $2,512 | $2,724 | $2,953 |
| Total Assets | $4,262 | $3,130 | $3,976 | $3,524 | $4,938 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10 | 10 | 10 | 10 | 6 |
| Accounts payable and accrued liabilities | 148 | 125 | 25 | 13 | 72 |
| TOTAL | $345 | $215 | $128 | $68 | $124 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1 | 12 | 22 | 36 | 44 |
| Other Non-Current Liabilities | 402 | 315 | 225 | 185 | 156 |
| TOTAL | $1 | $12 | $22 | $41 | $58 |
| Total Liabilities | $346 | $227 | $150 | $110 | $182 |
| Shareholders' Equity | |||||
| Common Shares | 374 | 102 | 90 | 65 | 65 |
| Retained earnings | -38,492 | -36,681 | -34,644 | -32,293 | -30,920 |
| Other shareholders' equity | 11,822 | 11,927 | 11,832 | 11,336 | 11,386 |
| TOTAL | $4,317 | $3,219 | $4,051 | $3,599 | $4,911 |
| Total Liabilities And Equity | $4,664 | $3,445 | $4,200 | $3,709 | $5,094 |